lacosamide and Gastroenteritis

lacosamide has been researched along with Gastroenteritis* in 1 studies

Other Studies

1 other study(ies) available for lacosamide and Gastroenteritis

ArticleYear
A trial of lacosamide for benign convulsions with gastroenteritis.
    Brain & development, 2020, Volume: 42, Issue:7

    Benign convulsions with gastroenteritis are characterized by a cluster of seizures. Sodium channel blockers are efficacious. We prescribed lacosamide, a new channel blocker, for five patients. Patient age ranged from 17 to 33 months; all five experienced 1-4 generalized convulsions persisting for 30-120 s. One patient exhibited a transient splenial lesion on head magnetic resonance imaging. All received one dose (2 mg/kg) of lacosamide. The convulsions ceased, and no adverse drug effect was noted. A single dose of lacosamide was effective and well-tolerated in five patients with benign convulsions with gastroenteritis.

    Topics: Child, Preschool; Female; Gastroenteritis; Humans; Infant; Lacosamide; Male; Seizures; Voltage-Gated Sodium Channel Blockers

2020